Atlantic Edge Private Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Atlantic Edge Private Wealth Management's GILD Position: Q2 2026 in Review
Atlantic Edge Private Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 75 shares worth $9.48K. The position accounts for ﹤0.01% of the portfolio, ranked #425.
Atlantic Edge Private Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.5K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Atlantic Edge Private Wealth Management held 75 shares of Gilead Sciences worth $9.48K as of Q2 2026.
- Atlantic Edge Private Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #425 holding.
- Atlantic Edge Private Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
- Atlantic Edge Private Wealth Management's Gilead Sciences position peaked at $10.5K in Q1 2026.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.